<!DOCTYPE html>
<!--[if IE 9]><html lang="en-US" class="no-js ie-9"> <![endif]-->
<!--[if gt IE 9]><!--> <html lang="en-US" class="no-js"><!--<![endif]-->
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<title>MoFo Life Sciences</title>
<meta name="description" itemprop="description" content>
<meta name="keywords" itemprop="keywords" content>
<link rel="canonical" href="http://lifesciences.mofo.com/">
<link rel="stylesheet" id="validate-engine-css-css" href="css/blog-validationEngine.jquery.css" type="text/css" media="all">
<link rel="stylesheet" id="fontello-css" href="css/blog-embedded.css" type="text/css" media="all">
<link rel="stylesheet" id="mofo-fonts-css" href="css/blog-fonts.css" type="text/css" media="all">
<link rel="stylesheet" id="child-normalize-css" href="css/blog-normalize.css" type="text/css" media="all">
<link rel="stylesheet" id="child-foundation-css" href="css/blog-foundation.css" type="text/css" media="all">
<link rel="stylesheet" id="child-style-css" href="css/blog-style.css" type="text/css" media="all">
<link rel="stylesheet" id="child-jetpack-css" href="css/blog-jetpack.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-custom-style.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-print.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-simple-nav.css" type="text/css" media="all">
<link rel="shortcut icon" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png" type="image/icon">
<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="favicon.ico">
<link rel="icon" href="favicon.ico" type="image/icon">
<link rel="apple-touch-icon" type="image/png" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone -->
<link rel="apple-touch-icon" type="image/png" sizes="72x72" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPad -->
<link rel="apple-touch-icon" type="image/png" sizes="114x114" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone4 -->
<link rel="stylesheet" href="css/jquery-ui.css">


    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-T8Z9VLF');</script>
    <!-- End Google Tag Manager -->


<script defer src="js/all.js" crossorigin="anonymous"></script>

<!-- Jetpack Open Graph Tags -->
<meta property="og:type" content="website">
<meta property="og:title" content="MoFo Life Sciences">
<meta property="og:description" content="Because No One is Immune to the Law">
<meta property="og:url" content="https://lifesciences.mofo.com/">
<meta property="og:site_name" content="MoFo Life Sciences">
<meta property="og:image" content="https://s0.wp.com/i/blank.jpg">
<meta property="og:locale" content="en_US">





<style>
.svg-inline--fa {

    /*height: .8em;*/

    }
.svg-inline--fa {
    width: .475em;
}
 .sd-content a.nc-facebook-circled{
     color: #3b5998;
     font-size: 30px;
     }
     .sd-content a.nc-linkedin-circled{
     color: #0077b5;
     font-size: 30px;
     }
     .sd-content a.nc-twitter-circled{
     color: #00acee;
     font-size: 30px;
     }
     .sd-content a.nc-fa-envelope-square{
     color: #034193 ;
     font-size: 30px;
     }  
     .sd-content a.nc-fa-print{
     color: #000 ;
     font-size: 30px;
     }                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
     .sd-content a hover {
     }
     .sd-content i {
      margin: -4px;
     }
     #searchsubmit {
      font-size: 1em;
      border-radius: 3px;
      font-family: 'Oswald';
      text-transform: uppercase;
      letter-spacing: 2px;
      border-style: solid;
      border-width: 0;
      font-weight: 500;
    }
</style>

<meta name="google-site-verification" content="OD6S3RPM-cQOknAs1uXmBRvRJyh28rwkOoqdes47ZUE">
</head>
<body class="home blog full-width custom-background-empty">
    <!-- Google Tag Manager (noscript) -->
    <noscript>
      <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T8Z9VLF" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->
    <script type="text/javascript"> 
<!-- 
var bb=new Image();var _ti=910;var _q="";var na=(navigator.appName=="Netscape");var ns=(navigator.appName.substring(0,9)=="Microsoft");var _qDate=new Date();var _r=(document.referrer.indexOf(getdomain(location))>-1?"":document.referrer);_q+="&5="+parseInt(_qDate.getTimezoneOffset());_q+="&35="+parseInt(_qDate.toString().indexOf("aylight")>-1?1:0);_q+="&6=903262831";_q+="&7=3262831";_q+="&8="+encodeURIComponent(document.location);_q+="&9="+encodeURIComponent(_r);_q+="&10="+encodeURIComponent(document.title);_q+="&11="+encodeURIComponent(navigator.userAgent);_q+="&12="+encodeURIComponent((na?navigator.language:navigator.userLanguage));_q+="&13="+((navigator.javaEnabled()?'1':'0'));if(document.cookie.indexOf("cc")==-1)document.cookie="cc=t;";_q+="&15="+((document.cookie.indexOf("cc")==-1)?"0":"1");_q+="&16="+encodeURIComponent((screen.width+'x'+screen.height));_q+="&17="+encodeURIComponent(((ns)?screen.colorDepth:screen.pixelDepth));_q+="&18="+encodeURIComponent(Math.random());_q+="&19="+_ti;bb.src="https://s.clickability.com/s?"+_q;
function setonclicks(a,b){var i=0;var retval=true;while(document.links[i]!=a){i++;}if(b.li[i])retval=b.li[i].oldonclick();bye(a);return retval;}
function newonld(){if(hasonload)oldonld();lnks=new Object();var sze=document.links.length;lnks.li=new Array(sze);for (var i=0; i<sze; i++){if(document.links[i].onclick){lnks.li[i]=document.links[i];lnks.li[i].oldonclick=document.links[i].onclick;}eval("document.links[i].onclick=function(){return setonclicks(this,lnks);}");}}function bye(a){if(a.href.toLowerCase().indexOf('http')!=0)return true;if(getdomain(location)==getdomain(a))return true;if(a.href.toLowerCase().indexOf('http')!=0)return true;var _qc="https://s.clickability.com/s?19=912";_qc+="&6=903262831";_qc+="&7=3262831";_qc+="&18="+encodeURIComponent(Math.random());_qc+="&100="+a.href;_qc+="&101="+encodeURIComponent(a.text);var cc=new Image();if(na){cc.src=_qc;pc(100);}else cc.src=_qc;return true;}function pc(a){d = new Date(); while (1){m =new Date(); df = m-d;if( df > a ) {break;}}}function getdomain(a){var i=a.host.indexOf(":");return (i>=0)?a.host.substring(0,i):a.host;}if(self['setupalready']){var dosetup = false;alert('There are two $imware.tracker calls on this page. Please alert Client Services');}else{var dosetup = true;var hasonload=false;}if(dosetup && ((window.screen)||((new Array()).toSource)||((new Array()).shift&&ns))&&(navigator.userAgent.indexOf('Mac')<0)){if(window.onload){oldonld=window.onload;hasonload=true;}window.onload=newonld;var setupalready = true;}//-->
</script><noscript>
<img alt="Clickability tracking pixel" width="1" height="1" src="https://s.clickability.com/s?19=990&amp;14=0&amp;6=903262831&amp;7=3262831&amp;25=0&amp;18=0.25364280754356505">
</noscript>

<div class="main-body-container" data-equalizer>    
<div class="nav_container">
	<a class="skip-link screen-reader-text" href="#content">Skip to content</a>  
        <div class="nav_wrap row ">
        	<div> <!-- add sticky here if needed -->
        	  <div>
                    <nav class="top-bar" data-topbar data-options="scrolltop:false;mobile_show_parent_link:false;">                  
                        <ul class="title-area">
	                        <li class="mofo-logo">
			                    <a href="https://www.mofo.com" title="Morrison & Foerster" target="_blank">
						<img src="https://media2.mofo.com/images/morrison-foerster-blog-logo.png" alt="logo">
			                    </a>
			                </li>
                            <li class="name">
                                <div class="header-title">
                                	<a href="index.html" title="MoFo Life Sciences" rel="home">
                                	                                	MoFo Life Sciences
                                	                                	</a>
                                </div>
                                                                <div class="header-subtitle">
                               		<span class="pms-7702c">Because No One is Immune to the Law</span>
                                </div>
                                                            </li>							
                            <!-- Remove the class "menu-icon" to get rid of menu icon. Take out "Menu" to just have icon alone -->
                                                    </ul>
</nav>
</div><!-- contain-to-grid sticky -->                
</div><!-- .row -->
</div>        
</div>
<!-- end .nav_container -->  


<div class="topnav" id="myTopnav">

<a href="index.html" class="active">Home</a>



<div class="divider"></div>
<div class="dropdown">

    <button class="dropbtn ">Topics 
     <i class="fa fa-caret-down"></i>
    </button>
    <div class="dropdown-content">

	
		 	<a href="topics_20.html">AI + Robotics</a>
		 	<a href="topics_5.html">Agtech</a>
		 	<a href="topics.html">Announcements</a>
		 	<a href="topics_2.html">Antitrust</a>
		 	<a href="topics_13.html">Asia</a>
		 	<a href="topics_9.html">Bioinformatics</a>
		 	<a href="topics_27.html">Biotech</a>
		 	<a href="topics_30.html">Blockchain</a>
		 	<a href="topics_6.html">CFIUS</a>
		 	<a href="topics_4.html">COVID-19</a>
		 	<a href="topics_16.html">Corporate + Venture Capital</a>
		 	<a href="topics_10.html">Data Analytics</a>
		 	<a href="topics_11.html">Digital Health</a>
		 	<a href="topics_23.html">Employment</a>
		 	<a href="topics_31.html">European Union</a>
		 	<a href="topics_18.html">FDA</a>
		 	<a href="topics_12.html">Financing</a>
		 	<a href="topics_29.html">Global</a>
		 	<a href="topics_21.html">Healthcare</a>
		 	<a href="topics_24.html">Intellectual Property</a>
		 	<a href="topics_3.html">Licensing + Commercial</a>
		 	<a href="topics_15.html">Litigation</a>
		 	<a href="topics_25.html">Medical Devices + Diagnostics</a>
		 	<a href="topics_17.html">Pharma</a>
		 	<a href="topics_19.html">Privacy + Data Security</a>
		 	<a href="topics_14.html">Product Liability + Class Action</a>
		 	<a href="topics_7.html">Rare Disease</a>
		 	<a href="topics_1.html">Regulatory</a>
		 	<a href="topics_26.html">Startup</a>
		 	<a href="topics_28.html">United Kingdom</a>
		 	<a href="topics_22.html">United States</a>
    </div>
  </div> 


<div class="divider"></div>
<a href="editors.html" class>Editors</a>


<div class="divider"></div>
<a href="about.html" class>About</a>


<div class="divider"></div>
<a href="javascript:void(0);" onclick="openSubscribeModal()" class>Subscribe</a>




<a href="javascript:void(0);" style="font-size:15px;" class="icon" onclick="myFunction()">&#9776;</a>
</div>


<div class="content_container">
    <section class="content_wrap row" role="document">
            <div id="main" role="main">
            <div class="medium-7 columns">
                <a href="welcome-to-mofo-life-sciences.html" title="Welcome to MoFo Life Sciences">
                    <img width="600" height="295" src="https://media2.mofo.com/images/life-sciences-featured-image.jpg" class="attachment-feature-image size-feature-image wp-post-image" alt>
                </a>
            </div>
            <div class="medium-5 columns">
                <div class="rockwell pms-7702c">
                   <a href="topics.html" rel="category tag">Announcements</a>
                </div>
                <h2>
                    <a href="welcome-to-mofo-life-sciences.html" title="Permalink to Welcome to MoFo Life Sciences" rel="bookmark">
                       Welcome to MoFo Life Sciences							
                    </a>
                </h2>                
                		 <p><i>MoFo Life Sciences</i> shares timely legal and business insights and in-depth analyses on trends and the complex technologies at the heart of the global pharmaceutical, biotechnology, diagnostics, medical devices, digital health, and AgTech fields.</p> 
                            </div>
            <div class="medium-12 columns">
                <hr>
            </div>
        </div>
                <div id="content" class="medium-8 large-8 columns" role="main">
        
              


    


    
<!-- #post -->          

  

 

            
            
            <article id="post-566353301" class="post-566353301 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="Global-IP-policy-in-the-age-of-AI.html" title="Global IP Policy in the Age of AI">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-ai-robotics.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>December 19, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_20.html" rel="category tag">AI + Robotics</a>, <a href="topics_10.html" rel="category tag">Data Analytics</a>, <a href="topics_29.html" rel="category tag">Global</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a></a>
                        </div>
                        <h3>
                            <a href="Global-IP-policy-in-the-age-of-AI.html" title="Permalink to Global IP Policy in the Age of AI" rel="bookmark">Global IP Policy in the Age of AI</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Karen G Potter
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									                        <p>Between 2013 and 2016, the number of Artificial Intelligence (AI) related patent applications in the life sciences and medical sciences grew by about 40%*, and, with continuing advances in technology, has likely increased substantially since 2016. Although this finding may not come as a<span class="moretag">
                                <a href="Global-IP-policy-in-the-age-of-AI.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

        
            
            <article id="post-566139351" class="post-566139351 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="crossing-borders-IP-Magazine.html" title="Crossing Borders">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-asia.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>December 12, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_13.html" rel="category tag">Asia</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_3.html" rel="category tag">Licensing + Commercial</a></a>
                        </div>
                        <h3>
                            <a href="crossing-borders-IP-Magazine.html" title="Permalink to Crossing Borders" rel="bookmark">Crossing Borders</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Janet Xiao
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						                        <p>Partner Janet Xiao, who leads the firm&rsquo;s China Life Sciences Group, co-authored an article with associate Can Cui for Intellectual Property Magazine, titled &ldquo;Crossing Borders,&rdquo; which explores technology transfer opportunities emerging from import rules in China.

The authors note that Chinese companies are eager to<span class="moretag">
                                <a href="crossing-borders-IP-Magazine.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

    
            
            <article id="post-566139191" class="post-566139191 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="EU-adopts-whistleblowing-directive-to-protect-whistleblowers.html" title="EU Adopts Whistleblowing Directive to Protect Whistleblowers">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-privacy-data-security.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>December 11, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_31.html" rel="category tag">European Union</a>, <a href="topics_19.html" rel="category tag">Privacy + Data Security</a></a>
                        </div>
                        <h3>
                            <a href="EU-adopts-whistleblowing-directive-to-protect-whistleblowers.html" title="Permalink to EU Adopts Whistleblowing Directive to Protect Whistleblowers" rel="bookmark">EU Adopts Whistleblowing Directive to Protect Whistleblowers</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Alja Poler De Zwart
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		                        <p>The whistleblowing rules in Europe are about to change dramatically. The new Directive on the protection of persons who report breaches of Union law, also referred to as the &ldquo;Whistleblowing Directive,&rdquo; will require Member States to create rules that mandate organizations with more than<span class="moretag">
                                <a href="EU-adopts-whistleblowing-directive-to-protect-whistleblowers.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

            
            
            <article id="post-565999761" class="post-565999761 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="striking-balance-trade-secret-and-corporate-espionage-disputes.html" title="Striking the Balance in Trade Secret and Corporate Espionage Disputes">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-litigation.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>December 9, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_17.html" rel="category tag">Pharma</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="striking-balance-trade-secret-and-corporate-espionage-disputes.html" title="Permalink to Striking the Balance in Trade Secret and Corporate Espionage Disputes" rel="bookmark">Striking the Balance in Trade Secret and Corporate Espionage Disputes</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Matthew A. Chivvis
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													                        <p>In 2017, the Commission on the Theft of American Intellectual Property issued a report to Congress estimating that the theft of trade secrets could cost the United States economy as much as $600 billion annually. In the years following, news reports indicate that alleged<span class="moretag">
                                <a href="striking-balance-trade-secret-and-corporate-espionage-disputes.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                            
            
            <article id="post-565338762" class="post-565338762 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="FDA-approves-25th-biosimilar.html" title="FDA Approves 25th Biosimilar">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-intellectual-property.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>November 22, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_27.html" rel="category tag">Biotech</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_17.html" rel="category tag">Pharma</a>, <a href="topics_1.html" rel="category tag">Regulatory</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="FDA-approves-25th-biosimilar.html" title="Permalink to FDA Approves 25th Biosimilar" rel="bookmark">FDA Approves 25th Biosimilar</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				                        <p>On November 15, Pfizer&rsquo;s adalimumab product became the 25th biosimilar approved by FDA under the Biologics Price Competition and Innovation Act (BPCIA).  The road to the 25th approval has been long and has involved some of the biggest companies and medications in the<span class="moretag">
                                <a href="FDA-approves-25th-biosimilar.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

            
            
            <article id="post-564107871" class="post-564107871 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="reflecting-on-data-at-hitachi-social-innovation-forum-2019.html" title="Reflecting on the Challenges and Opportunities of Data at the Hitachi Social Innovation Forum 2019 ">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-ai-robotics.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>October 30, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_20.html" rel="category tag">AI + Robotics</a>, <a href="topics_13.html" rel="category tag">Asia</a>, <a href="topics_10.html" rel="category tag">Data Analytics</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a></a>
                        </div>
                        <h3>
                            <a href="reflecting-on-data-at-hitachi-social-innovation-forum-2019.html" title="Permalink to Reflecting on the Challenges and Opportunities of Data at the Hitachi Social Innovation Forum 2019 " rel="bookmark">Reflecting on the Challenges and Opportunities of Data at the Hitachi Social Innovation Forum 2019 </a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Ani Hamparsumyan
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															                        <p>Are companies keeping up with technological advances, and what are they doing specifically to contribute to society and provide value? What are the future prospects, and what kind of opportunities are being created for progress, including in the digital and scientific arenas?

As Japanese companies<span class="moretag">
                                <a href="reflecting-on-data-at-hitachi-social-innovation-forum-2019.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

        
            
            <article id="post-564232861" class="post-564232861 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="foreign-investment-2020-CFIUS-spotlight-on-TID-US-businesses.html" title="Foreign Investment 2020: CFIUS Spotlight on “TID” U.S. Businesses">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-regulatory.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>October 15, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_6.html" rel="category tag">CFIUS</a>, <a href="topics_1.html" rel="category tag">Regulatory</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="foreign-investment-2020-CFIUS-spotlight-on-TID-US-businesses.html" title="Permalink to Foreign Investment 2020: CFIUS Spotlight on “TID” U.S. Businesses" rel="bookmark">Foreign Investment 2020: CFIUS Spotlight on “TID” U.S. Businesses</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Nicholas J. Spiliotes, Charles L. Capito, and Joseph A. Benkert
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														                        <p>FIRRMA directed the U.S. Department of the Treasury (&ldquo;Treasury&rdquo;), as the chair of CFIUS, to issue regulations that, among other things, address national security concerns arising from foreign investment in U.S. businesses with critical technologies, critical infrastructure, and personal data (referred to in the<span class="moretag">
                                <a href="foreign-investment-2020-CFIUS-spotlight-on-TID-US-businesses.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                
            
            <article id="post-561872301" class="post-561872301 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="China-patent-eligibility-update-human-embryonic-stem-cells.html" title="China Patent Eligibility Update: Human Embryonic Stem Cells">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-asia.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>October 1, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_13.html" rel="category tag">Asia</a>, <a href="topics_27.html" rel="category tag">Biotech</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_3.html" rel="category tag">Licensing + Commercial</a>, <a href="topics_1.html" rel="category tag">Regulatory</a></a>
                        </div>
                        <h3>
                            <a href="China-patent-eligibility-update-human-embryonic-stem-cells.html" title="Permalink to China Patent Eligibility Update: Human Embryonic Stem Cells" rel="bookmark">China Patent Eligibility Update: Human Embryonic Stem Cells</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										                        <p>On September 23, 2019, China National Intellectual Property Administration (&ldquo;CNIPA&rdquo;) announced its proposed amendments to China&rsquo;s Guideline on Patent Examination (the &ldquo;Guideline&rdquo;), which is the counterpart of the Manual of Patent Examining Procedure in the U.S.  The proposed amendments will become effective November<span class="moretag">
                                <a href="China-patent-eligibility-update-human-embryonic-stem-cells.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

        
            
            <article id="post-561336311" class="post-561336311 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="foreign-investment-2020-key-takeaways-from-the-modernized-CFIUS-reg.html" title="Foreign Investment 2020: Key Takeaways from the “Modernized” CFIUS Regulations">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-regulatory.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>September 25, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_6.html" rel="category tag">CFIUS</a>, <a href="topics_1.html" rel="category tag">Regulatory</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="foreign-investment-2020-key-takeaways-from-the-modernized-CFIUS-reg.html" title="Permalink to Foreign Investment 2020: Key Takeaways from the “Modernized” CFIUS Regulations" rel="bookmark">Foreign Investment 2020: Key Takeaways from the “Modernized” CFIUS Regulations</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                By: Nicholas J. Spiliotes, Joseph A. Benkert, and Charles L. Capito
                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											                        <p>After more than a year of anticipation, the U.S. Department of the Treasury (&ldquo;Treasury&rdquo;) has released proposed regulations to implement the Foreign Investment Risk Review Modernization Act (FIRRMA). These proposed regulations follow an initial round of FIRRMA-implementing regulations issued in October 2018, which most<span class="moretag">
                                <a href="foreign-investment-2020-key-takeaways-from-the-modernized-CFIUS-reg.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
            
 

                        
            
            <article id="post-560783861" class="post-560783861 post type-post status-publish format-standard has-post-thumbnail hentry ">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="Artificial-Intelligence-and-Pharma.html" title="Artificial Intelligence and Pharma">
                                                          <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-ai-robotics.jpg)"></div>
                                                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                    <div class="rockwell pms-7702c">
                            <em>September 19, 2019</em>
                            - <a href="topics_8.html" rel="category tag"><a href="topics_20.html" rel="category tag">AI + Robotics</a>, <a href="topics_10.html" rel="category tag">Data Analytics</a>, <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_17.html" rel="category tag">Pharma</a>, <a href="topics_14.html" rel="category tag">Product Liability + Class Action</a>, <a href="topics_1.html" rel="category tag">Regulatory</a>, <a href="topics_22.html" rel="category tag">United States</a></a>
                        </div>
                        <h3>
                            <a href="Artificial-Intelligence-and-Pharma.html" title="Permalink to Artificial Intelligence and Pharma" rel="bookmark">Artificial Intelligence and Pharma</a>
                        </h3>
                        <div class="entry-meta">
                            <div class="blog-author-meta subheader">			
                                                                

                                                                                            </div>
                        </div>
                                                
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														                        <p>Bethany Hills authored an article for PHARMAnetwork, covering how the pharmaceutical industry has been adopting artificial intelligence and machine learning. Bethany discusses that the pharmaceutical sector has been one of the more robust areas where private partnerships with artificial intelligence-based technology companies have developed.<span class="moretag">
                                <a href="Artificial-Intelligence-and-Pharma.html"> &hellip;&rsaquo;</a>
                        </span>
                        </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                        <ul class="pagination clearfix">
                <li class></li>
             

                        
                                                

                <li><a href="index_16.html">« Previous</a></li>
                                
                                    <li><a href="index_13.html">13</a>
                        </li>
                                    <li><a href="index_12.html">14</a>
                        </li>
                                    <li><a href="index_15.html">15</a>
                        </li>
                                    <li><a href="index_16.html">16</a>
                        </li>
                                    <li class="current"><a href="#">17</a>
                        </li>
                                    <li><a href="index_19.html">18</a>
                        </li>
                                    <li><a href="index_18.html">19</a>
                        </li>
                                    <li><a href="index_20.html">20</a>
                        </li>
                                    <li><a href="index_21.html">21</a>
                        </li>
                                    <li><a href="index_22.html">22</a>
                        </li>
                 
        
                                                
             
                <li class></li>
            </ul>
                </div>
                <!-- #content -->
                <div id="secondary" class="medium-4 large-4 columns widget-area data-equalizer-watch" role="complementary">
                        

<aside id="black-studio-tinymce-3" class="widget widget_black_studio_tinymce">
    <div class="textwidget">
        <div class="gray-sidebar">
            <h5>Stay Connected </h5>
                                        <a title="Connect via LinkedIn" class="nc-linkedin-circled" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via Twitter" class="nc-twitter-circled" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons black85"></i>
                    </a>
                            </div>
    </div>
</aside>
<aside id="search-2" class="widget widget_search">
    <form role="search" method="get" id="searchform" action="/search/">
        <div class="row collapse">
            <div class="medium-12 large-12 columns">
                <input type="text" value name="s" id="s">
                    <div class="search-icon">
                        <i class="icon-search footer-icons pms-7702c"></i>
                    </div>
                    <input type="submit" id="searchsubmit" value="Search" class="search-btn">
                    </div>
</div>
</form>
</aside>
<aside id="categories-2" class="widget widget_categories">
    <h6 class="widget-title">Topics</h6>
            <label class="screen-reader-text" for="cat">Topics</label>
            <select name="cat" id="cat" class="postform">
                <option value="-1">Topics</option>
                                                                                                                                                <option class="level-0" value="1457511">AI + Robotics</option>
                                                                                                <option class="level-0" value="1457521">Agtech</option>
                                                                                                <option class="level-0" value="1457691">Announcements</option>
                                                                                                <option class="level-0" value="1462201">Antitrust</option>
                                                                                                <option class="level-0" value="1457531">Asia</option>
                                                                                                <option class="level-0" value="1468521">Bioinformatics</option>
                                                                                                <option class="level-0" value="1456751">Biotech</option>
                                                                                                <option class="level-0" value="1458171">Blockchain</option>
                                                                                                <option class="level-0" value="1458511">CFIUS</option>
                                                                                                <option class="level-0" value="1462211">COVID-19</option>
                                                                                                <option class="level-0" value="1457541">Corporate + Venture Capital</option>
                                                                                                <option class="level-0" value="1458861">Data Analytics</option>
                                                                                                <option class="level-0" value="1465651">Digital Health</option>
                                                                                                <option class="level-0" value="1458521">Employment</option>
                                                                                                <option class="level-0" value="1457551">European Union</option>
                                                                                                <option class="level-0" value="1459381">FDA</option>
                                                                                                <option class="level-0" value="1457561">Financing</option>
                                                                                                <option class="level-0" value="1459511">Global</option>
                                                                                                <option class="level-0" value="1459951">Healthcare</option>
                                                                                                <option class="level-0" value="1457581">Intellectual Property</option>
                                                                                                <option class="level-0" value="1457591">Licensing + Commercial</option>
                                                                                                <option class="level-0" value="1457601">Litigation</option>
                                                                                                <option class="level-0" value="1459061">Medical Devices + Diagnostics</option>
                                                                                                <option class="level-0" value="1457631">Pharma</option>
                                                                                                <option class="level-0" value="1457641">Privacy + Data Security</option>
                                                                                                <option class="level-0" value="1457651">Product Liability + Class Action</option>
                                                                                                <option class="level-0" value="1465361">Rare Disease</option>
                                                                                                <option class="level-0" value="1459071">Regulatory</option>
                                                                                                <option class="level-0" value="1459521">Startup</option>
                                                                                                <option class="level-0" value="1462611">United Kingdom</option>
                                                                                                <option class="level-0" value="1457671">United States</option>
                                                            </select>
            <script type="text/javascript">
                /* <![CDATA[ */
                (function() {
                var dropdown = document.getElementById( "cat" );
                function onCatChange() {
                if ( dropdown.options[ dropdown.selectedIndex ].value > 0 ) {
                location.href = "/topics/?c=" + dropdown.options[ dropdown.selectedIndex ].value;
                }
                }
                dropdown.onchange = onCatChange;
                })();
                /* ]]> */
            </script>
</aside>
<aside id="text-2" class="widget widget_text">
<h6 class="widget-title"></h6>
<h5>Subscribe</h5>
<p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
<iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowtransparency="true" style="border: 0;"></iframe>
<h6 class="widget-title"></h6>
<h5>Resources</h5>
<ul>
<li><a href="https://www.mofo.com/capabilities/life-sciences-healthcare.html" target="_blank">Life Sciences and Healthcare Group</a></li>
<li><a href="https://www.mofo.com/special-content/life-sciences-podcast.html" target="_blank">Life Sciences Podcast</a></li>
<li><a target="_blank" href="https://www.mofo.com/capabilities/patent-counseling-prosecution.html">Patent Counseling + Prosecution</a></li>
<li><a target="_blank" href="https://www.mofo.com/capabilities/fda-life-sciences-compliance.html">FDA Regulatory + Life Sciences Compliance</a></li>
<li><a target="_blank" href="https://www.mofo.com/capabilities/life-sciences-transactions-licensing.html">Life Sciences Transactions + Licensing</a></li>
</ul>
<h6 class="widget-title"></h6>
<h5>Editors</h5>
<div class="text-center"><img alt="Wolfgang Shonig" src="https://media2.mofo.com/images/schonig_wolfgang_blog_150x150.png" scale="0"></div>
<h5 class="text-center">Wolfgang Sch&ouml;nig</h5>
<div class="rockwell text-center subheader">Partner</div>
<p class="bio">Wolfgang Sch&ouml;nig advises clients on IP aspects relating to transactions in, among others, the life sciences, AgTech and pharmaceuticals industry, as well as legal representation in IP disputes. His additional focus areas include research and development collaborations, complex licensing agreements, technology acquisitions, know-how protection strategies, and employee invention law. <a href="https://www.mofo.com/people/wolfgang-schonig.html" target="_blank">More &rsaquo;</a></p>
<div class="text-center"><img alt="Anita Choi" src="https://media2.mofo.com/images/choi_anita_blog_150x150.png" scale="0"></div>
<h5 class="text-center">Anita Choi</h5>
<div class="rockwell text-center subheader">Partner</div>
<p class="bio">Anita Choi&rsquo;s practice focuses on patent prosecution, portfolio management, IP due diligence, and IP litigation support. Her clients range from early-stage start-up enterprises to established domestic and international companies. She is well-versed in building and managing worldwide patent portfolios across many sectors and technologies, including small-molecule pharmaceuticals, medical devices, diagnostics, industrial chemicals and advanced materials, food and agtech. <a href="https://www.mofo.com/people/anita-choi.html" target="_blank">More &rsaquo;</a></p>
<div class="text-center"><img alt="Stacy Amin" src="https://media2.mofo.com/images/amin_stacy_blog_150x150.png" scale="0"></div>
<h5 class="text-center">Stacy Amin</h5>
<div class="rockwell text-center subheader">Partner</div>
<p class="bio">Stacy Cline Amin leads the FDA Regulatory &amp; Compliance practice within the firm&rsquo;s Global Life Sciences + Healthcare Group and provides strategic regulatory and business advice to companies in the life sciences, healthcare, and technology industries. Stacy previously served as Chief Counsel of the U.S. Food and Drug Administration (FDA) and Deputy General Counsel of the Department of Health and Human Services (HHS), and held senior positions within the White House Counsel&rsquo;s Office and health committees in both the House and Senate. With her depth of experience across government agencies, she provides clients with an insider&rsquo;s perspective on regulatory and compliance issues, enforcement actions, and litigation challenges. <a href="https://www.mofo.com/people/stacy-amin.html" target="_blank"> More &rsaquo;</a></p>
</aside>
<aside class="widget widget_recent_entries">
    <h6 class="widget-title">Recent Posts</h6>
            <ul>
                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force-part-3-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE (PART 3 OF 3)</a>
                    </li>
                                                                    <li>
                        <a href="fda-will-once-again-accept-pre-submissions-for-all-in-vitro-diagnostic-tests.html">FDA Will Once Again Accept Pre-Submissions for All In Vitro Diagnostic Tests</a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-2-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 2 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-1-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 1 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="senators-call-for-report-on-state-of-psychedelic-research.html">Senators Call for Report on State of Psychedelic Research</a>
                    </li>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </ul>
</aside>
<aside id="black-studio-tinymce-6" class="widget widget_black_studio_tinymce">
     <style>

address {
  font-style: normal;
  margin-bottom: 14px;
  margin-left: 10px;
}

address .contact  {
  display: block;
  
}

address .email a:hover {
  color: #0078a0;
}

.location, .attorney, .email {
  display: block;

}

address .email a {
color: #5e5f61;
}

.location {
  font-weight: 900;
  font-family: 'Oswald', sans-serif;
  text-transform: uppercase;
}

.contact-title {
  font-family: 'Oswald', sans-serif;
  font-size: .825em;
  background-color: #eeeeee;
  padding: .8em;
  letter-spacing: 2px;
  text-transform: uppercase;
  margin-bottom: 10px;
  display: block;
  font-weight: 900;
}

</style>

  


</aside>
                </div>
<!-- #secondary -->
</section>
<!-- end .content-wrap -->
                    </div>
                    <!-- end .content_container -->
                    <div style="display:none;" id="dialog-message" title="Email Disclaimer">
	<p>Unsolicited e-mails and information sent to Morrison &amp; Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison &amp; Foerster. If you are not already a client of Morrison &amp; Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.</p>
</div>
<div class="footer_container">
    <footer class="footer_wrap row" role="contentinfo">
        <div id="footer" class="row" role="contentinfo">
            <div class="columns medium-12 footer-nav-wrapper">
                <div class="footer-nav">
                    <ul>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-terms-of-use">
                            <a target="_blank" href="https://www.mofo.com/about/terms-notices.html">Terms of Use</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-cookies">
                            <a target="_blank" href="https://www.mofo.com/about/cookies.html">Cookies</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-privacy-policy">
                            <a target="_blank" href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-disclaimer">
                            <a target="_blank" href="https://www.mofo.com/special-content/blog-disclaimer/">Disclaimer</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-attorney-advertising">
                            <a target="_blank" href="https://www.mofo.com/about/attorney-advertising.html">Attorney Advertising</a>
                        </li>
                        </ul></div>
                </div>
                <div class="columns medium-12 text-center">
                    <p class="copyright">&copy;1996-2022 Morrison &amp; Foerster LLP. <span class="show-for-small"><br></span>All Rights Reserved.</p>
                </div>
                <div class="medium-2 medium-centered columns">
                                                            <a title="Connect via LinkedIn" class="nc-linkedin" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via Twitter" class="nc-twitter" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons pms-7702c"></i>
                    </a>
                                    </div>
                                            </div>
</footer>
<!-- .row -->
</div>
<!-- end #footer_container -->
<div id="backtotop" class="hvr-fade">
    <span class="genericon genericon-collapse"></span>
</div>
<!-- #backtotop -->

</div>
     <div class="textwidget">
        <div id="subscribe-modal" class="reveal-modal" data-reveal aria-labelledby="subscribe-modal" aria-hidden="true" role="dialog">
            <aside class="widget widget_black_studio_tinymce">
                <div class="textwidget newsletter_subscribe">
                    <div>
                        <h5>Subscribe</h5>
                                <p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
                    </div>
                </div>
                            </aside>
            <p>
                <div class="resultLabel"></div>
                <div class="widget_wysija_cont shortcode_wysija newsletter_subscribe">
                                   <iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowTransparency="true" style="border: 0"></iframe>
                                                </div>
                    <a class="close-reveal-modal" onClick="closeSubscriptionModal()" aria-label="Close"></a>
</p></div>
</div>



<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-12456654-15', 'auto');   ga('send', 'pageview');
</script>

<script type="text/javascript"> 
/*<![CDATA[*/ 
(function() { 
var sz = document.createElement('script'); sz.type = 'text/javascript'; sz.async = true; 
sz.src = '//siteimproveanalytics.com/js/siteanalyze_59840.js'; 
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(sz, s); 
})(); 
/*]]>*/ 
</script>




<script>
  function myFunction() {
    var x = document.getElementById("myTopnav");
    if (x.className === "topnav") {
      x.className += " responsive";
    } else {
      x.className = "topnav";
    }
  }
  </script>
  
  
  <script>
  

function openSubscribeModal() {
console.log('openSubscribeModal')
  var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'visible';
  m.style.display = 'block';
  }
  
  function closeSubscriptionModal() {
    var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'hidden';
  m.style.display = 'none';
  }

  </script>
  

</body>
</html>




